These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8372548)

  • 1. Can arginase be a marker of the large bowel neoplasia?
    Konarska L; Kolasa T; Albrecht P; Reguła A
    Acta Biochim Pol; 1993; 40(1):164-6. PubMed ID: 8372548
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia.
    Sträter J; Wiesmüller C; Perner S; Kuefer R; Möller P
    Histopathology; 2008 Feb; 52(3):399-402. PubMed ID: 18081815
    [No Abstract]   [Full Text] [Related]  

  • 4. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical studies of the colonic mucosa in ulcerative colitis and other colonic diseases.
    Binder V
    Scand J Gastroenterol; 1968; 3(6):611-21. PubMed ID: 5731260
    [No Abstract]   [Full Text] [Related]  

  • 7. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the role of intraluminal proteolytic enzymes and intracellular enzyme inhibitors in ulcerative colitis.
    Goldberg DM; Campbell R; Roy AD
    Br J Exp Pathol; 1972 Aug; 53(4):359-73. PubMed ID: 4538442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia.
    Yuan M; Xhang X; Leu Y; Xu Y; Ullah N; Lawson M; Tobi M
    Cancer Lett; 2006 Apr; 235(1):48-52. PubMed ID: 15893419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arginase as a marker of cancerogenesis. I. Monitoring patients after resection of colorectal cancer].
    Porembska Z; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2002 Oct; 13(76):284-5. PubMed ID: 12557431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzymatic avtivity of the small intestinal mucosa in ulcerative colitis].
    Kojecký Z; Matlocha Z
    Vnitr Lek; 1967 Sep; 13(9):872-8. PubMed ID: 6081658
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa.
    Nishioka K; Grossie VB; Chang TH; Ajani JA; Ota DM
    J Surg Oncol; 1991 Jun; 47(2):117-20. PubMed ID: 2062082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for carcinoma of the pelvic ileal pouch/anal canal in ulcerative colitis.
    Elkowitz D; Daum F; Markowitz J; Proccaccino J; Boas E; Cuomo J; Kahn E
    Ann Clin Lab Sci; 2004; 34(2):143-9. PubMed ID: 15228225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pathogenesis of ulcerative colitis-associated colorectal cancer].
    Sipos J
    Magy Onkol; 2004; 48(1):35-43. PubMed ID: 15105894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enzyme activity of large intestine mucosa in non-specific ulcerative colitis].
    Iukhvidova ZhM; Rogozina VA; Zinov'ev OI
    Sov Med; 1984; (11):38-43. PubMed ID: 6084307
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arginase a marker of cancerogenesis. II. Monitoring of patients after resection of colorectal liver metastases].
    Porembska Z; Nyckowski P; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2002 Oct; 13(76):286-8. PubMed ID: 12557432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
    Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
    Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma.
    Porembska Z; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
    Cancer; 2002 Jun; 94(11):2930-4. PubMed ID: 12115381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.